| Serial Number | 79202821 |
| Word Mark | VECTURA |
| Filing Date | Friday, November 25, 2016 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, June 7, 2024 |
| Registration Number | 5337619 |
| Registration Date | Tuesday, November 21, 2017 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 5, 2017 |
| Description of Mark | The mark consists of a letter "V" made up of 6 oblique lines and a small triangle. The upper right corner of the "V" is blue and the lower left corner is blue. The mark also features the word "VECTURA" in blue. The background of the mark is white. |
| Description of the Colors Claimed | Green upper right corner of "V" device; blue lower left corner of "V" device; blue wording. |
| Goods and Services | Pharmaceutical and biological preparations for medical purpose, namely for the treatment of diseases or conditions of the respiratory system; pharmaceutical and biological preparations for medical purposes, namely the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and biological preparations for medical purposes, namely for the alleviation or prevention of pain or inflammation; pharmaceutical and biological preparations for medical purposes, namely, powders for asthma inhalers; pharmaceutical and biological preparations for medical purposes, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genitourinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purpose, namely, medicaments for inhalation therapy; pharmaceutical and biological preparations for medical purposes, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; pharmaceutical and biological preparations for medical purpose, namely medicaments for the treatment of erectile dysfunction, medicaments for the treatment of chronic obstructive pulmonary disease, medicaments for the treatment of premature ejaculation, medicaments for the treatment of cystic fibrosis, medicaments for the treatment of female sexual dysfunction, medicaments for the treatment of migraines, and medicaments for the treatment of asthma |
| Indication of Colors claimed | The color(s) blue, green, and white is/are claimed as a feature of the mark. |
| Goods and Services | Drug delivery devices, namely, drug delivery systems; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods |
| Goods and Services | Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing namely device and product testing of drug delivery devices and medical preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, June 7, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, June 7, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, June 7, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Vectura Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Vectura Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Vectura Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, March 9, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 10, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, March 11, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, March 14, 2017 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, March 15, 2017 | NON-FINAL ACTION WRITTEN |
| Thursday, March 16, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, March 16, 2017 | REFUSAL PROCESSED BY MPU |
| Thursday, March 16, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sunday, April 2, 2017 | REFUSAL PROCESSED BY IB |
| Thursday, July 20, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 20, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 21, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 16, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 5, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 5, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 21, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, February 21, 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, March 2, 2018 | FINAL DISPOSITION PROCESSED |
| Saturday, March 3, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, April 27, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Sunday, July 23, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, November 21, 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, December 22, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, June 7, 2024 | CANCELLED SECTION 71 |
| Saturday, October 8, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |